News for Healios K.K. (HLOSF)

The surge in demand for intracranial stents is predominantly driven by the growing occurrence of neurological conditions like intracranial stenosis and...

Athersys, Inc. , a cell therapy and regenerative medicine company developing MultiStem® for critical care indications, announces it has entered into a warrant exercise inducement offer letter to...

HEALIOS K.K. conducted the TREASURE study to investigate the safety and efficacy of HLCM051 in patients with ischemic stroke. Healios is continuing discussions with the regulatory authority ...

/PRNewswire/ -- DelveInsight's Medical Second Opinion Market Insights report provides the current and forecast market analysis, individual leading medical...

North America held largest share of global cell therapy market, which was valued at USD 7,820.35 million in 2020 and is expected to grow at a CAGR of 4.5%...

The global macular degeneration treatment market size was valued at USD 8,208.70 million in 2021. It is expected to reach USD 15,167.69 million by 2030,...

Advancing Cell Therapy Manufacturing: Meeting the Growing Demand for Safe and Effective Cellular Therapies...

Acute Respiratory Distress Syndrome Therapeutics Market by Drug Class (Bronchodilators, Corticosteroids, Antimicrobial Agents, and Other Drug Class) and by...

Visiongain has published a new report entitled Stem Cell Technologies and Applications 2022-2032. It includes profiles of Stem Cell Technologies and...

Visiongain has published a new report entitled Stem Cell Technologies and Applications 2022-2032. It includes profiles of Stem Cell Technologies and...